A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis
一项针对重症脓毒症患者的lexipafant（血小板激活因子受体拮抗剂）输注的双盲安慰剂对照研究
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.44.3.693-696.2000
Suputtamongkol, Y; Intaranongpai, S; Smith, M D; Angus, B; Chaowagul, W; Permpikul, C; Simpson, J A; Leelarasamee, A; Curtis, L; White, N J
